Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.

about

Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.

P2860

Q52576433-31C5C08B-3C47-42EE-AE32-B30EDB317F04

P2860

Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.

Item

http://www.wikidata.org/entity/Q41610540

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Characterization of the novel ...... fect on canine lymphoma cells.

@en

type

Item

label

Characterization of the novel ...... fect on canine lymphoma cells.

@en

prefLabel

Characterization of the novel ...... fect on canine lymphoma cells.

@en

P1476

Characterization of the novel ...... fect on canine lymphoma cells.

@en

P2093

Anahit Pews-Davtyan

http://www.w3.org/2001/XMLSchema#string

Anett Sekora

http://www.w3.org/2001/XMLSchema#string

Arndt Rolfs

http://www.w3.org/2001/XMLSchema#string

Barbara C Rütgen

http://www.w3.org/2001/XMLSchema#string

Bertram Brenig

http://www.w3.org/2001/XMLSchema#string

Catrin Roolf

http://www.w3.org/2001/XMLSchema#string

Christian Junghanss

http://www.w3.org/2001/XMLSchema#string

Ekkehard Schütz

http://www.w3.org/2001/XMLSchema#string

Ingo Nolte

http://www.w3.org/2001/XMLSchema#string

Julia Beck

http://www.w3.org/2001/XMLSchema#string

P2860

GAGE: generally applicable gene set enrichment for pathway analysis

Fast and accurate short read alignment with Burrows-Wheeler transform

Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma

Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells.

Principles of treatment for canine lymphoma.

IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma.

Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications

P304

35379-35389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.9297

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthias Beller

Hugo Murua Escobar

P577

2016-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27177088

http://www.w3.org/2001/XMLSchema#string

P932

5085236

http://www.w3.org/2001/XMLSchema#string

Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.

about

P2860

P2860

Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932